|Preserve the tech transfer process at research universities- engagement opportunity on March In RightsLast month, the Biden Administration announced a plan to dramatically reinterpret the Bayh-Dole Act, which allows academic institutions to directly protect and commercialize discoveries arising from federally funded research on their campuses.
The White House has proposed that the government be allowed to “march in” and forcibly re-license patents that result from federally-funded research. There is a growing concern that the government could use this change in policy to control the prices of thousands of products, including medicines and medical devices. This change could potentially impact the longstanding culture of research, innovation, and entrepreneurship at research universities across the country.
The National Institute of Standards and Technology (NIST) seeks comments on these policy changes from stakeholders.
Please consider responding to the NIST in opposition of these policy changes. The current tech transfer process is critical for drug innovation and research and development. Comments close 5pm on February 6th.
|BioCT’s 2024 Legislative Agenda is available. Our mission is to provide education and advocacy for Connecticut’s life science community at the policy level and ensure synergy of action and alignment of state and federal initiatives that have a significant impact on our members.Find the full agenda can be found on our website
|We are pleased to welcome two new companies, Avian Vaccine Services (AVS Bio) and Talam Biotech to our Groton incubator, BioCT Innovation Commons.
- AVS Bio is the world’s largest and most trusted producer of Specific Pathogen Free (SPF) eggs and adjacent laboratory products and services for the development and manufacture of biologics.
- Talam Biotech is leading the development of solutions that enable farmers to produce healthier, more sustainable food. At Talam, they leverage the power of naturally occurring soil microbes to reduce food-associated contaminants and remediate pollutants
Virtus Therapeutics and Curatix also expanded their footprint adding another laboratory.
- Curatix LLC focuses on the development of new antimicrobial therapies and therapeutic strategies with a specific focus on antifungal and anti-parasitic drugs and diagnostic tests.
- Virtus Therapeutics (C-corp) is focused on the development of the first treatment for pantothenate kinase-associated neurodegeneration (PKAN) using small molecule activators.
Contact Kim Kelly if you are interested in space opportunities.
|Welcome Adventus ConsultingAdventus Consulting helps rapidly growing life science companies harness supplier value by developing procurement & sourcing processes supportive of growth, risk and cost management goals. Working with finance, legal, operational and procurement teams, they foster collaboration between company and supplier stakeholders to create an efficient corporate buying process across sourcing, contracting, and payment activities.
Adventus Consulting believes the procurement function should support the business and not create an inefficient bureaucracy of confusing policies, processes and disconnected systems. They recognize each client’s situation and objectives to work with them to design and implement a procurement function to meet their business goals.
To learn more about Adventus Consulting and how they can help you, please check out the following articles written by Managing Partner, David Stowe.Financial Leadership of Strategic Procurement Strategic Procurement for Emerging Pharma & Biotech Betting the House: CDMO Selection for Emerging Pharma Are your Suppliers Supporting Your Growth? How Procurement Efficiencies Help Drive Growth De-Risking Sourcing in the Pharmaceutical Industry Preparing for the Next Disruption Can Procurement be a Trusted Advisor?
|Annual Stand Up for STEM Mentorship AwardsMillion Women Mentors Connecticut (MWM-CT) announces the annual 2024 Stand Up for STEM- Mentorship Awards, to recognize and elevate those who continue to mentor women and girls to pursue and persist in STEM careers. Now is the time to identify those incredible students, role models, companies and organizations in Connecticut who deserve to be honored for their efforts to attract, advance, retain and promote women and girls in the fields of Science, Technology, Engineering and Math.
Nominate a company, or an individual, here
|CASE CT Medal of TechnologyThe nomination period for the 2024 Connecticut Medal of Technology is now open. The Medal is Connecticut’s highest honor for technological achievement in fields crucial to the state’s economic competitiveness and well-being. Two medals will be awarded, with one medal for an individual and one medal for a team, company/non-profit or divisions of companies/non-profits.
Nominate an individual here
|Applications open for Blavatnik Fellows
Application reviews will take place on a rolling basis. Final deadline to apply is February 15
The Blavatnik Fellowship is a one-year fellowship designed for high-potential life science industry professionals with advanced technical skills who have an interest in joining the Yale and New Haven life sciences entrepreneurial ecosystem. Blavatnik Fellows assist Yale faculty members and their research teams to fully explore the commercial potential of their breakthrough life science technologies. They work closely with staff and faculty teams that receive support from The Blavatnik Fund for Innovation at Yale, a $65 million fund run by Yale Ventures that develops and translates Yale’s groundbreaking research into innovative healthcare solutions.
Fellows should have the ability to create business strategies for innovative projects, with particular interest in applications from candidates interested/experienced in digital health and med tech. Learn more and hear from past fellows here
|2024 Taiwan and U.S. Precision Medicine Industry Technology and Investment SeminarThis event serves as a strategic platform for biotechnology enterprises with promising development trajectories to connect with the capital market. Specifically targeting biomedical companies from Taiwan and the U.S., this gathering showcases cutting-edge technologies such as precision detection and treatment.
This event aims to catalyze increased investment and collaboration opportunities within Taiwan’s biomedical industry, fostering a dynamic biotech venture capital market. U.S. startups specializing in precision medicine and actively seeking potential investors are cordially invited to participate.
Hybrid Format: Taipei (in person); US (online)
Time: 09:00-3:30 pm EST, Early April 2024
To express your interest, kindly provide pertinent details, including your company’s website, a designated contact person and email, along with a concise overview of your company’s activities. Kindly direct your submissions to Scott Yeh at email@example.com.
|We are in full blown events season. Right on the heels of our Legislative Breakfast last Monday, last night we co-hosted the New Haven Recap of the 42nd Annual J.P. Morgan Healthcare Conference for founders, CEOs, and CFOs. This is a new model for BioCT that is working out well. We are partnering with member organizations to jointly host events to educate, develop, and connect our workforce, each bringing to the table what we do best – for BioCT it’s content, speakers, and filling any room.
Our next statewide event is a Rare Disease Forum March 7th co-hosted at The Jackson Laboratory for Genomic Medicine. This event is particularly meaningful to me – it was in 2016 I made a decision to focus full time on rare disease and first stepped foot in New Haven, joining Achillion Pharmaceuticals. As many in our ecosystem know, once you join the Rare community it’s impossible to leave.
It’s time that we all show our support not only to this community, but to Farmington.
We have limited sponsorships, an opportunity for advocacy groups to exhibit and attend free, and registration is open. Please note that we expect space to sell out quickly for this one. You can reserve a spot here.
Please always reach out with any questions, ideas, requests or feedback – I am still receiving post Legislative Breakfast emails and every single one makes my day.
— Jodie GillonPresident and CEO
|Join us for an afternoon of industry-led discussions on innovation in rare disease diagnostics and treatments, along with the promising impact of these advancements on patient outcomes.Sponsorships are on a first-come, first-served basis. Interested parties should reach out to Jodie Gillon (firstname.lastname@example.org)
|Leadership of Innovation: Building Strategic Leadership Skills in Science & Technology – Hosted by WESTTuesday, February 6, 6:00 – 7:30 pmLeaders in the science and technology industries face extraordinary challenges – and opportunities – because they work in highly innovative organizations which feature…GNHCC Regional Workforce Summit Thursday, February 15, 3:00 – 6:00 pmThe summit will focus on strategies to retain and attract talent to our region. We’re partnering with our local colleges and universities to engage students and businesses for networking…Collaborative Connecticut Thursday, February 15, 5:00 – 7:00 pmJoin us at Da Legna at Nolo for a cash bar, tasty pizza sponsored by ZehnTek, and networking!BIO CEO & Investor Conference Monday, February 26 – Tuesday, February 27Don’t miss one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of…Rare Disease Day Forum Thursday, March 7, 1:30 – 4:30 pmJoin us for an afternoon of industry-led discussions on innovation in rare disease diagnostics and treatments, along with the promising impact of these advancements on patient outcomes.Yale Innovation Summit Wednesday, May 29 – Thursday, May 30The Yale Innovation Summit convenes the innovation and entrepreneurship community for two days of impactful conversations, purposeful networking, and Yale pitch competition across five…